Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - matrix of stakeholders
|
Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - matrix of stakeholders
12 May 2015 (99.61 Kb 29 sec) |
This page was last updated: 11 May 2015